Smith & Nephew (SNN) Research & Development (2009 - 2024)
Smith & Nephew's (SNN) quarterly Research & Development came in at -$137.0 million in Q4 2024, up 17.47% YoY from -$116.6 million in Q1 2024, and up 17.47% on a QoQ basis from -$166.0 million in Q4 2023.
Smith & Nephew (SNN) Research & Development (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has 16 years of Research & Development data on file, last reported at -$137.0 million in Q4 2024.
- Quarterly Research & Development rose 17.47% year-over-year to -$137.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$648.0 million (up 1.67% YoY) and the FY2025 annual result came in at $296.0 million, up 2.42% from the prior year.
- Research & Development grew to -$137.0 million in Q4 2024, from -$166.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of -$137.0 million in Q4 2024 to a low of -$174.0 million in Q4 2022.
- A 5-year average of -$159.2 million and a median of -$166.0 million in 2023 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2020 — Research & Development jumped 49.32% — and 2021, when it fell 15.54%.
- Tracing SNN's Research & Development over 5 years: stood at -$148.0 million in 2020, then fell by 15.54% to -$171.0 million in 2021, then fell by 1.75% to -$174.0 million in 2022, then climbed by 4.6% to -$166.0 million in 2023, then rose by 17.47% to -$137.0 million in 2024.
- The last three Research & Development figures came in at -$137.0 million (Q4 2024), -$166.0 million (Q4 2023), and -$174.0 million (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 196.58 Bn | 190.98 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Stryker | 127.35 Bn | 123.88 Bn | 4.50 Bn | 434.00 Mn |
| 3 | Medtronic | 118.25 Bn | 109.03 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 74.32 Bn | 73.78 Bn | 3.85 Bn | 554.00 Mn |
| 5 | Edwards Lifesciences | 52.61 Bn | 48.36 Bn | 1.35 Bn | 278.90 Mn |
| 6 | Dexcom | 34.26 Bn | 33.16 Bn | 830.00 Mn | 153.00 Mn |
| 7 | GE HealthCare Technologies | 32.92 Bn | 30.82 Bn | 2.18 Bn | 323.00 Mn |
| 8 | Smith & Nephew | 26.16 Bn | 25.41 Bn | - | - |
| 9 | Koninklijke Philips | 25.91 Bn | 22.58 Bn | 4.55 Bn | -1.02 Bn |
| 10 | Steris | 22.74 Bn | 22.25 Bn | 684.20 Mn | 28.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -137.00 Mn |
| Dec 31, 2023 | -166.00 Mn |
| Dec 31, 2022 | -174.00 Mn |
| Dec 31, 2021 | -171.00 Mn |
| Dec 31, 2020 | -148.00 Mn |
| Dec 31, 2019 | -292.00 Mn |
| Dec 31, 2018 | -246.00 Mn |
| Dec 31, 2017 | -223.00 Mn |
| Dec 31, 2016 | -230.00 Mn |
| Dec 31, 2015 | -222.00 Mn |
| Dec 31, 2014 | -235.00 Mn |
| Sep 30, 2014 | -57.00 Mn |
| Mar 31, 2014 | -58.00 Mn |
| Dec 31, 2013 | -231.00 Mn |
| Mar 31, 2013 | -62.00 Mn |
| Dec 31, 2012 | -171.00 Mn |
| Jun 30, 2012 | -39.00 Mn |
| Mar 31, 2012 | -46.00 Mn |
| Dec 31, 2011 | -167.00 Mn |
| Sep 30, 2011 | -126.00 Mn |